不同冠状动脉搭桥技术治疗冠心病的研究进展

Abstract
Figure/Table
References (29)
Related Citation (2)

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract [Abstract]Coronary artery bypass grafting (CABG)is the main treatment programme for multiple vessel lesions of coronary atherosclerosis.With the development in recent decades,great progress has been made in bypass technology from the initial cardiopulmonary bypass,the later non-cardiopulmonary bypass,to minimally invasive small incision and robot-assisted bypass.Minimally invasive surgery has been paid more and more attention because it reduces trauma and recovery time.In order to increase the patency rate of vascular graft,external stent and “on touch” technology have been developed.Moreover,hybrid surgery has combined the advantages of bypass and percutaneous coronary intervention(PCI)to better benefit patients.In addition,adjuvant molecular therapy can provide alternative microvascular revascularization for patients who are not suitable for traditional coronary artery revascularization.This paper summarizes the new progress of bypass technology in recent years.

Key words： Extravascular stents Robotic surgery Coronary artery bypass grafting Adjunctive molecular therapies

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2019/V26/I7/25

[16]	Woo YJ.Robotic cardiac surgery[J].Int J Med Robot，2006，2（3）：225-232.
[21]	杨旭，马润伟，宋怡，等.分站式杂交手术治疗冠心病多支病变效果观察[J].山东医药，2016，56（26）：58-60.
[22]	田军，董丹.杂交技术治疗冠状动脉多支病变病人的护理[J].全科护理，2016，14（5）：469-471.
[1]	李继峰.药物洗脱支架与冠状动脉搭桥术对糖尿病合并冠脉三支病变的疗效对比[J].现代诊断与治疗，2018，29（5）：680-682.
[2]	Spadaccio C，Benedetto U.Coronary artery bypass grafting（CABG） vs.percutaneous coronary intervention （PCI） in the treatment of multivessel coronary disease：quo vadis？ -a re-view of the evidences on coronary artery disease[J].Ann Cardiothorac Surg，2018，7（4）：506-515.
[3]	郭占芳，梁向党，孙赓，等.3种血管外支架预防静脉移植再狭窄效果对比研究[J].现代中西医结合杂志，2015，24（13）：1369-1371.
[4]	Taggart DP，Amin S，Djordjevic J，et al.A prospective study of external stenting of saphenous vein grafts to the right coronary artery：the VEST Ⅱ study[J].Eur J Cardiothorac Surg，2017，51（5）：952-958.
[5]	Dashwood MR，Tsui JC.“No-touch” saphenous vein harvesting improves graft performance in patients undergoing coronary artery bypass surgery：a journey from bedside to bench[J].Vascul Pharmacol，2013，58（3）：240-250.
[6]	Papakonstantinou NA，Baikoussis NG，Goudevenos J，et al.Novelnotouchtechniqueofsaphenousveinharvesting：isgreat graft patency rate provided？[J].Ann Card Anaesth，2016，19（3）：481-488.
[7]	Samano N，Geijer H，Bodin L，et al.The no-touch saphenous vein graft in elderly coronary bypass patients with multiple comorbidities is a promising conduit to substitute the left internal thoracic artery[J].J Thorac Cardiovasc Surg，2017，154（2）：457-466.
[8]	朱龙金，刘帅洲，张涛，等.微创左胸小切口冠脉搭桥术的临床研究[J].安徽医药，2017，21（1）：106-109.
[9]	李继峰.胸部小切口冠状动脉搭桥术的临床应用效果研究[J].实用中西医结合临床，2017，17（10）：31-32.
[10]	Raja SG，Benedetto U，Alkizwini E，et al.Propensity score adjusted comparison of MIDCAB versus full sternotomy left anterior descending artery revascularization[J].Innovations （Phila），2015，10（3）：174-178.
[13]	Chiu KM，Chen RJ.Videoscope-assisted cardiac surgery[J].J Thorac Dis，2014，6（1）：22-30.
[14]	刘盛华，陈海生.胸腔镜辅助与前正中开胸非体外循环下冠状动脉旁路移植术乳内动脉桥猪模型的对比研究[J].岭南现代临床外科，2017，17（1）：68-71.
[15]	陈海生，刘盛华，吴丽映，等.胸腔镜辅助冠状动脉旁路移植术的应用[J].岭南现代临床外科，2015，15（2）：191-193.
[11]	Deppe AC，Liakopoulos OJ，Kuhn EW，et al.Minimally invasive direct coronary bypass grafting versus percutaneous coronary intervention for single-vessel disease：a meta-analysis of 2885 patients[J].Eur J Cardiothorac Surg，2015，47（3）：397-406.
[12]	Martinovic I，Lindemann S，Irqsusi M，et al.Minimally invasive direct coronary bypass surgery via distal mini-sternotomy：promising clinical Results with anaortic，multivessel，all-arterial technique[J].Herz，2018.[Epub ahead of print]
[17]	Moscarelli M，Harling L，Ashrafian H，et al.Challenges facing totally endoscopic robotic coronary artery bypass grafting[J].Int J Med Robot，2015，11（1）：18-29.
[18]	Ezelsoy M，Oral K，Caynak B，et al.Pain and the quality of life following robotic assisted minimally invasive surgery[J].Heart Surg Forum，2016，19（4）：E165-E168.
[19]	Halkos ME，Liberman HA，Devireddy C，et al.Early clinical and angiographic outcomes after robotic-assisted coronary artery bypass surgery[J].J Thorac Cardiovasc Surg，2014，147（1）：179-185.
[20]	Giambruno V，Chu MW，Fox S，et al.Robotic-assisted coronary artery bypass surgery：an 18-year single-centre experience[J].Int J Med Robot，2018，14（3）：e1891.
[23]	Hu FB，Cui LQ.Short-term clinical outcomes after hybrid coronary revascularization versus off-pump coronary artery bypass for the treatment of multivessel or left main coronary artery disease：a meta-analysis[J].Coron Artery Dis，2015，26（6）：526-534.
[24]	Serruys PW，Chevalier B，Dudek D，et al.A bioresorbable everolimus-eluting scaffold versus a metallic everolimuseluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions （ABSORB Ⅱ）：an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial[J].Lancet，2015，385（9962）：43-54.
[25]	Halkos ME，Walker PF，Vassiliades TA，et al.Clinical and angiographic Results after hybrid coronary revascularization[J].Ann Thorac Surg，2014，97（2）：484-490.
[26]	Zhu P，Zhou P，Sun Y，et al.Hybrid coronary revascularization versus coronary artery bypass grafting for multivessel coronary artery disease：systematic review and meta-analysis[J].J Cardiothorac Surg，2015，10：63.
[27]	Harskamp RE，Brennan JM，Xian Y，et al.Practice patterns and clinical outcomes after hybrid coronary revascularization in the United States：an analysis from the society of thoracic surgeons adult cardiac database[J].Circulation，2014，130（11）：872-879.
[28]	Konstanty-Kalandyk J，Piatek J，Kedziora A，et al.Tenyear follow-up after combined coronary artery bypass grafting and transmyocardial laser revascularization in patients with disseminated coronary atherosclerosis[J].Lasers Med Sci，2018，33（7）：1527-1535.
[29]	Giusti II，Rodrigues CG，Salles FB，et al.High doses of vascular endothelial growth factor 165 safely，but transiently，improve myocardial perfusion in no-option ischemic disease[J].Hum Gene Ther Methods，2013，24（5）：298-306.